Association of calpain (Ca2+-dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts

Journal of Cellular Biochemistry

Volumn 74, Issue 4, 1999, Pages 522-531

  Barnoy, Sivia ^a   Zipser, Yehudit ^a   Glaser, Tova ^a   Grimberg, Yelena ^a   Kosower, Nechama S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Calpain calpastatin association; Myoblast calpain; Myoblast calpastatin; Myoblast differentiation

Indexed keywords

CALPAIN; CALPASTATIN; CYTOSKELETON PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL LYSATE; CELL MEMBRANE; CONFORMATIONAL TRANSITION; CROSS LINKING; CROSS REACTION; IMMUNOPRECIPITATION; MEMBRANE FUSION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; TISSUE SPECIFICITY;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CALPAIN; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; MICROSCOPY, FLUORESCENCE; MUSCLES; PRECIPITIN TESTS; RATS;

EID: 0033567878     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990915)74:4<522::AID-JCB2>3.0.CO;2-I     Document Type: Article

References (49)

1. Barnoy S, Glaser T, Kosower NS. 1996. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion. Biochem Biophys Res Commun 220:933-938.
2. Barnoy S, Glaser T, Kosower NS. 1997. Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors. Biochim Biophys Acta 1358:181-188.
3. Barnoy S, Glaser T, Kosower NS. 1998. The calpain-calpastatin system and protein degradation in fusing myoblasts. Biochim Biophys Acta 1402:52-60.
4. 2+-induced conformational changes. Nature Struct Biol 4:532-538.
5. Burg LD, Furlong MT, Harrison ML, Geahlen RL. 1994. Interactions of Lyn with the antigen receptor during B cell activation. J Biol Chem 269:28136-28142.
6. Carafoli E, Molinari M. 1998. Calpain: a protease in search of a function? Biochem Biophys Res Commun 247:193-203.
7. Constantin B, Cognard C, Raymond G. 1995. Myoblast fusion requires cytosolic calcium elevation but not activation of voltage dependent calcium channels. Cell Calcium 19:365-374.
8. Crawford C, Brown NR, Willis AC. 1993. Studies of the active site of m-calpain and the interaction with calpastatin. Biochem J 296:135-142.
9. Croall DE, McGrody KS. 1994. Domain structure of calpain: mapping the binding site for calpastatin. Biochemistry 33:13223-13230.
10. Glaser T, Kosower NS. 1986. Calpain-calpastatin and fusion. Fusibility of erythrocytes is determined by a protease-protease inhibitor [calpain-calpastatin] balance. FEBS Lett 206:115-120.
11. 2+-dependent thiol protease) in erythrocytes of young and old individuals. Proc Natl Acad Sci USA 91:7879-7883.
12. Ilian MA, Foresberg NE. 1992. Gene Expression of calpains and their specific endogenous inhibitor calpastatin, in skeletal muscle of fed and fasted rabbits. Biochem J 287:163-171.
13. 2+ on binding of the calpains to calpastatin. J Biol Chem 264:17888-17896.
14. Karlsson JO, Nilsson M. 1997. Extra-lysosomal proteolysis and expression of calpains and calpastatin in cultured thyroid cells. Cell Biol Int 21:167-174.
15. Kawasaki H, Kawashima S. 1996. Regulation of the calpain-calpastatin system by membranes. Mol Membr Biol 13: 217-224.
16. Kawasaki H, Emori Y, Suzuki K. 1993. Calpastatin has two distinct sites for interaction with calpain-effect of calpastatin fragments on the binding of calpain to membranes. Arch Biochem Biophys 305:467-472.
17. Kosower NS, Glaser T. 1990. The calpain calpastatin system and membrane fusion. In: Mellgren RL, Murachi T, editors. Intracellular calcium-dependent proteolysis. Boca Raton, FL: CRC Press. p 163-180.
18. Kosower NS, Glaser T, Kosower EM. 1983. Membrane mobility agent-promoted fusion of erythrocytes: fusibility is correlated with attack by calcium activated cytoplasmic proteases on membrane proteins. Proc Natl Acad Sci USA 75:7542-7546.
19. Lane RD, Allan DM, Mellgren RL. 1992. A comparison of the intracellular distribution of μ-calpain, m-calpain and calpastatin in proliferating A431 cells. Exp Cell Res 203:5-16.
20. Lee WJ, Ma H, Takano E, Vang HQ, Hatanaka M, Maki M. 1992. Molecular diversity in amino terminal domain of human calpastatin by exon skipping. J Biol Chem 267: 8437-8442.
21. Lin G-d, Chattopadhyay D, Maki M, Wang KKW, Carson M, Jin L, Yuen P-W, Takano E, Hatanaka M, Delucas LJ, Narayana SVL. 1997. Crystal structure of calcium bound domain VI of calpain at 1.9 A resolution and its role in enzyme assembly, regulation and inhibitor binding. Nature Struct Biol 4:539-547.
22. Lowry OH, Rosenbrough NJ, Farr A, Randell RJ. 1951. Protein measurement with folin phenol reagent. J Biol Chem 193:265-275.
23. Ma H, Yang HQ, Takano E, Lee WJ, Hatanaka M, Maki M. 1993. Requirement of different subdomains of calpastatin for calpain inhibition and for binding to calmodulin-like domains. J Biochem 113:591-599.
24. Medvedeva ND, Alexeyev VY, Tsupkina NV, Nikolsky NN. 1992. A 66-kDa protein associated with epidermal growth factor receptor is a proteolytic fragment of phosphoinositide-specific phospholipase C. FEBS Lett 356:299-301.
25. Mellgren RL. 1987. Calcium-dependent proteases: an enzyme system active at cellular membranes? FASEB J 1:110-115.
26. Mellgren RL, Song K, Mericle MT. 1993. m-Calpain requires DNA for activity on nuclear proteins at low calcium concentrations. J Biol Chem 268:653-657.
27. Mellgren RL, Lu Q. 1994. Selective nuclear transport of μ-calpain. Biochem Biophys Res Commun 204:544-550.
28. Melloni E, Michetti M, Salamino F, Minafra R, Pontremoli S. 1996. Modulation of the calpain autoproteolysis by calpastatin and phospholipids. Biochem Biophys Res Commun 229:193-197.
29. Melloni E, Michetti M, Salamino F, Pontremoli S. 1998. Molecular and functional properties of a calpain activator protein specific for μ-isoforms. J Biol Chem 273: 12827-12831.
30. 2 in Swiss 3T3 fibroblasts. J Biol Chem 273:29986-29994.
31. 2+-activated neutral protease is activated in the erythrocyte membrane in its nonautolyzed 80 kDa form. J Biol Chem 269:27992-27995.
32. Mooren FC, Kinne RKH. 1998. Cellular calcium in health and disease. Biochim Biophys Acta 1406:127-151.
33. Morimoto T, Ginsberg MD, Dietrich WD, Zhao W. 1997. Hyperthermia enhances spectrin breakdown in transient focal cerebral ischemia. Brain Res 746:43-51.
34. 2+ dependent protease (calpain) and its high molecular weight endogenous inhibitor (calpastatin). Adv Enzyme Regul 19:407-424.
35. Murray SS, Grisanti MS, Bentley GV, Kahn AJ, Urist MR, Brochmann Murray EJ. 1997. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells. Exp Cell Res 233:297-309.
36. Nishimura T, Goll DE. 1991. Binding of calpain fragments to calpastatin. J Biol Chem 266:11842-11850.
37. Nixon RA, Saito KI, Grynspan F, Griffin WR, Katayama S, Honda T, Mohan PS, Shea TB, Beerman M. 1994. Calcium-activated neutral proteinase system in aging and Alzheimers disease. Ann NY Acad Sci 747:77-91.
38. Ono Y, Sorimachi H, Suzuki S. 1998. Structure and physiology of calpain, an enigmatic protease. Biochem Biophys Res Commun 245:289-294.
39. Rapaport D, Greenberg DS, Tal M, Yaffe D, Nudel U. 1993. Dp71, the nonmuscle product of the Duchenne muscular dystrophy gene is associated with the cell membrane. FEBS Lett 328:197-202.
40. Saido TC, Sorimachi H, Suzuki K. 1994. Calpains: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J 8:814-822.
41. Salamino F, Averna M, Tedesco I, De Tullio R, Melloni E, Pontremoli S. 1997. Modulation of rat brain calpastatin efficiency by post translational modifications. FEBS Lett 412:433-438.
42. Schollmeyer JE. 1986. Possible role of calpain I and calpain II in differentiating muscle. Exp Cell Res 163:413-422.
43. Schwarz-Benmeir N, Glaser T, Barnoy S, Kosower NS. 1994. Calpstatin in erythrocytes of young and old individuals. Biochem J 304:365-370.
44. Shanmugam M, Krett NL, Peters CA, Maizels ET, Murad FM, Kawakatsu H, Rosen ST, Hunzicker-Dunn M. 1998. Association of PKCδ and active Src in PMA-treated MCF-7 human breast cancer cells. Oncogene 16:1649-1998.
45. Shields DC, Tyor WR, Deibler GE, Hogan EL, Banik NL. 1998. Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 95:5768-5772.
46. Spencer MJ, Tidball JG. 1996. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. Exp Cell Res 226:264-272.
47. Willingham MC. 1994. Fluorescence labeling of intracellular antigens of attached or suspended tissue-culture cells. In: Javois LC, editor. Immunocytochemical methods and protocols. Totowa, NJ: Humana Press. p 131-142.
48. Yang HQ, Ma H, Takano E, Hatanaka M, Maki M. 1994. Analysis of calcium-dependent interaction between amino-terminal conserved region of calpastatin functional domain and calmodulin-like domain of μ-calpain large subunit. J Biol Chem 269:18977-18984.
49. Zipser Y, Kosower NS. 1996. Phosphotyrosine phosphatase associated with band 3 protein in the human erythrocyte membrane. Biochem J 314:881-887.